Catherine Bouvier, INCA President and Co-Founder and CEO of Neuroendocrine Cancer UK, has dedicated the past twenty years of her career with an aim to improve the care and outcomes for neuroendocrine cancer patients. As the first dedicated neuroendocrine cancer nurse specialist in the UK, and setting up the first UK-wide charity, Catherine has experienced extensive challenges, alongside a significant sense of achievement. Her passion is to see eight strategic priorities in the neuroendocrine cancer field achieved: the protection of world class service; improving impact and outcomes for patients who follow a less common pathway; establishing patient experience as being on a par with clinical effectiveness and safety; promoting the necessary investment to deliver a modern and high-quality service for patients, both in the acute and community setting; the provision of standardized useful and accurate patient information; a significant increase in the research, education and awareness in neuroendocrine cancers; ensuring commissioning processes are fit for purpose, and that our community has the attention that is the right of all cancer patients.